HomeInsights52 Week High Stocks

Eris Lifesciences Ltd 52 Week High

Eris Lifesciences Ltd 52 Week High

stocks purchased

₹ 0.2 Cr

Volume Transacted

(Dec 26, 2024)

stocks purchased

1.8 K

Stocks Traded

(Dec 26, 2024)

Last Updated on: Dec 26, 2024

Image

ERIS Lifesciences Ltd

NSE: ERIS

YEARHIGH

₹ 1593

Last updated on: Dec 26, 2024

Key Highlights

  • The 52 Week HIGH of ERIS Lifesciences Ltd is ₹ 1593 as of 26 Dec 24 .

Company Fundamentals for ERIS Lifesciences Ltd

No data available

Market Price of ERIS Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring ERIS Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 20241353.8
24 Dec 20241342.5
23 Dec 20241334.65
20 Dec 20241378.25
19 Dec 20241395.45
18 Dec 20241389.7
17 Dec 20241412.55
16 Dec 20241412.1
13 Dec 20241467.45
12 Dec 20241517

Asset Value vs Market Value of ERIS Lifesciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of ERIS Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of ERIS Lifesciences Ltd

No data available

* All values are in crore

ERIS Lifesciences Ltd News Hub

News

Board of Eris Lifesciences approves acquisition of 30% stake in Levim Lifetech

The Board of Eris Lifesciences at its meeting held on 25 October 2024 has approved the exe...

Read more

25 Oct 2024 18:47

News

ERIS Lifesciences announces board meeting date

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 25 Octob...

Read more

22 Oct 2024 15:56

News

ERIS Lifesciences to convene AGM

ERIS Lifesciences announced that the 18th Annual General Meeting (AGM) of the company will...

Read more

05 Aug 2024 18:42

News

ERIS Lifesciences announces board meeting date

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 2 August...

Read more

31 Jul 2024 12:40

News

Eris Lifesciences allots 22,492 equity shares under ESOP

Eris Lifesciences has allotted 22,492 equity shares under ESOP on 20 June 2024. The paid u...

Read more

24 Jun 2024 12:26

News

Board of ERIS Lifesciences approves composite scheme of arrangement

The Board of ERIS Lifesciences at its meeting held on 21 May 2024 has approved composite s...

Read more

21 May 2024 18:42

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of ERIS Lifesciences Ltd

What is the significance of ERIS Lifesciences Ltd reaching its 52-week high?

ERIS Lifesciences Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor ERIS Lifesciences Ltd 52-week high?

Investors monitor ERIS Lifesciences Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is ERIS Lifesciences Ltd a good buy when it hits its 52-week high?

Whether ERIS Lifesciences Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important ERIS Lifesciences Ltd fundamentals.

What should I consider before investing in ERIS Lifesciences Ltd at its 52-week high?

Before investing in ERIS Lifesciences Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can ERIS Lifesciences Ltd stock price continue to rise after reaching its 52-week high?

ERIS Lifesciences Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions